• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Shields Health Solutions, Duke Health to Advance Specialty Pharmacy in North Carolina

by Fred Pennic 05/14/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Shields Health Solutions (Shields), the nation’s premier specialty pharmacy accelerator, announced a significant partnership with Duke Health, a leading academic health system in North Carolina. 

– The expansion of Duke Specialty Pharmacy, supported by Shields, is strategically designed to provide superior support for patients managing complex, chronic conditions. This initiative aims to deliver lower costs, broader treatment options, and significantly enhanced medication management.

Personalized Care and Expanded Access for Duke Patients

Patients utilizing the expanded Duke Specialty Pharmacy will benefit from a highly personalized, patient-centered care model. Key advantages include:

  • Improved Medication Adherence: Through dedicated support and education.
  • Consistent Follow-Up: Regular check-ins to monitor progress and address concerns.
  • Proactive Side Effects Management: Strategies to mitigate and manage potential side effects of complex medications.
  • Financial Assistance Navigation: Access to programs designed to reduce out-of-pocket expenses.
  • Convenient Medication Delivery: Ensuring timely access to necessary treatments.

Furthermore, Shields’ extensive access to payer networks and a wide array of available drugs will offer Duke patients greater choice in their specialty pharmacy services, enabling more of them to receive care directly through Duke Specialty Pharmacy.

“Our partnership with Duke Health underscores the health system’s unwavering commitment to providing superior patient care and differentiated patient experiences,” said Michael Ham, CEO of Shields Health Solutions. “We look forward to working alongside Duke Health as it expands its specialty pharmacy services and its impact on complex patients in the greater Raleigh – Durham community.”

Shields Health Solutions brings a wealth of experience to this partnership, currently collaborating with nearly 80 health systems across the country. Their proven model consistently helps patients reduce co-pays, ensures prompt medication delivery, and significantly improves medication adherence rates, contributing to better overall health outcomes.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

Reach7 Diabetes Studios Founder Chun Yong on Reimagining Chronic Care with a Concierge Medical Model

Most-Read

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Preparing for the ‘Big Beautiful Bill’: How Digitization Can Streamline Medicaid Eligibility & Social Care Delivery

Evernorth Health Services Invests $3.5B in Shields Health Solutions

Evernorth Health Services Invests $3.5B in Shields Health Solutions

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

KLAS Report: Oracle Health Faces Customer Losses and Declining Satisfaction

Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

M&A:Tempus AI Acquires Digital Pathology Leader Paige for $81.25M

Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

Femtech: Mira Launches Ultra4™, the First At-Home Hormone Monitor with Lab-Quality Insights

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

How Healthcare CIOs Can Solve the Unstructured Data Crisis and Reduce Storage Costs

Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

Sage Growth Partners Report: Healthcare C-Suite Acknowledges AI Potential but Lacks Trust

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

EVERSANA and Waltz Health Merge to Redefine Pharmaceutical Commercialization

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Advancing Diabetes Care: Combating Burnout and Harnessing Technology

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |